FRI0439 The Role of the Myeloid Inflammatory Bone Marrow Compartment in Onset and Progression of Myocardial Fibrosis in Systemic Sclerosis von Haunerdinger, V., Pachera, E., Dobrota, R., Blyszczuk, P., Distler, O., Kania, G.

Volltext

OP0284 Long Noncoding RNA MIR503HG is a Novel Factor in the Pathogenesis of Systemic Sclerosis von Pachera, E., Assassi, S., Salazar Cintora, G., Frank-Bertoncelj, M., Haunerdinger, V., Dobrota, R., Brock, M., Vettori, S., Hellerbrand, C., Feghali-Bostwick, C., Distler, J., Kania, G., Distler, O.

Volltext

Slit2/Robo4 Signaling: Potential Role of a VEGF-Antagonist Pathway to Regulate Luteal Permeability von Bekes, I., Haunerdinger, V., Sauter, R., Holzheu, I., Janni, W., Wöckel, A., Wulff, C.

Volltext

HLA-DR15 molecules jointly shape an autoreactive T cell repertoire in multiple sclerosis von Wang, J, Jelcic, I, Muhlenbruch, L, Haunerdinger, V, Toussaint, NC, Zhao, Y, Cruciani, C, Faigle, W, Naghavian, R, Foege, M, Binder, TMC, Eiermann, T, Opitz, L, Fuentes-Font, L, Reynolds, R, Kwok, WW, Nguyen, JT, Lee, J-H, Lutterotti, A, Munz, C, Rammensee, H-G, Hauri-Hohl, M, Sospedra, M, Stevanovic, S, Martin, R

Volltext

Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis von Felber, Matthias, Steward, Colin G., Kentouche, Karim, Fasth, Anders, Wynn, Robert F., Zeilhofer, Ulrike, Haunerdinger, Veronika, Volkmer, Benjamin, Prader, Seraina, Gruhn, Bernd, Ehl, Stephan, Lehmberg, Kai, Müller, Daniel, Gennery, Andrew R., Albert, Michael H., Hauck, Fabian, Rao, Kanchan, Veys, Paul, Hassan, Moustapha, Lankester, Arjan C., Schmid, Jana Pachlopnik, Hauri-Hohl, Mathias M., Güngör, Tayfun

Volltext

Slit2/Robo4 Signaling: Potential Role of a VEGF-Antagonist Pathway to Regulate Luteal Permeability von Bekes, I., Haunerdinger, V., Sauter, R., Holzheu, I., Janni, W., Wöckel, A., Wulff, C.

Volltext

Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis von Felber, M., Steward, C.G., Kentouche, K., Fasth, A., Wynn, R.F., Zeilhofer, U., Haunerdinger, V., Volkmer, B., Prader, S., Gruhn, B., Ehl, S., Lehmberg, K., Muller, D., Gennery, A.R., Albert, M.H., Hauck, F., Rao, K., Veys, P., Hassan, M., Lankester, A.C., Schmid, J.P., Hauri-Hohl, M.M., Gungor, T.

Volltext bestellen

A targetable type III immune response with increase of IL-17A expressing CD4 + T cells is associated with immunotherapy-induced toxicity in melanoma von Dimitriou, Florentia, Cheng, Phil F, Saltari, Annalisa, Schaper-Gerhardt, Katrin, Staeger, Ramon, Haunerdinger, Veronika, Sella, Federica, Tastanova, Aizhan, Urban, Christian, Dettwiler, Susanne, Mihic-Probst, Daniela, Matter, Christian M, Michielin, Olivier, Gutzmer, Ralf, Long, Georgina V, Becher, Burkhard, Levesque, Mitchell P, Dummer, Reinhard

Volltext

A targetable type III immune response with increase of IL-17A expressing CD4$^{+}$ T cells is associated with immunotherapy-induced toxicity in melanoma von Dimitriou, Florentia, Cheng, Phil F, Saltari, Annalisa, Schaper-Gerhardt, Katrin, Staeger, Ramon, Haunerdinger, Veronika, Sella, Federica, Tastanova, Aizhan, Urban, Christian, Dettwiler, Susanne, Mihic-Probst, Daniela, Matter, Christian M, Michielin, Olivier, Gutzmer, Ralf, Long, Georgina V, Becher, Burkhard, Levesque, Mitchell P, Dummer, Reinhard

Volltext